3t Biosciences

Next-generation TCR immunotherapies for solid tumors and immune-mediated diseases

Built from URL

OncologyCancer CareLife SciencesBiotechDrug Discovery

AboutBuilt from URL

3T Biosciences is an immunotherapy company focused on developing next-generation T-cell receptor (TCR) therapeutics for the treatment of solid tumors and other immune-mediated diseases. The company works on identifying novel targets to address a major bottleneck in targeted biotherapeutics in oncology. Their approach aims to enable transformative therapies for broad patient populations.

Problem

See something off about this company?